Advancing Breast Cancer Screening with a Non-Invasive Blood Test
At BCAL Diagnostics Limited, we believe early and accurate detection is key to improving breast cancer outcomes. As an Australian biotechnology company, we are pioneering a non-invasive blood test designed to complement existing breast screening methods and provide women with greater confidence in their care.
BREASTEST plus™ is a first-in-class blood test designed to be used alongside standard mammogram in breast cancer screening.
Developed in partnership with clinicians, BREASTEST plus™ provides additional information for women with high dense breast tissue – to help rule out the presence of breast cancer.
Call 1300 222 539 to learn more about BCAL Diagnostics products and ongoing research.
1 in 7 Women in Australia Will Be Diagnosed with Breast Cancer in their lifetime*
Our Mission
For over a decade, BCAL Diagnostics has been committed to developing innovative, accessible technologies that enhance breast cancer screening.
Our mission is to partner with clinicians and empower women through early, accurate breast cancer diagnostics—improving outcomes and confidence in care.
Designed to Complement Mammography
Our first-in-class blood test is designed to work alongside mammography, providing an added layer of screening for women with dense breast tissue. Complementing traditional imaging, the test helps rule out breast cancer, improving diagnostic accuracy and confidence in care.
By complementing traditional screening methods, BREASTEST plus™ supports clinicians in assessing breast health to help rule out breast cancer as part of a comprehensive screening approach.
Jayne Shaw Co-Founder and Executive Chair, Dr John Hurrell Non-Executive Director and Consultant, Shane Ryan Chief Executive Officer
About us
BCAL Diagnostics Limited is led by a team of experts with deep experience in biotechnology, diagnostics, and healthcare innovation. Our leadership is dedicated to advancing scientific excellence and bringing practical, life-changing solutions to improve health outcomes for women.
Dedicated to Advancing Early Detection
BCAL Diagnostics is committed to transforming breast cancer screening with innovative, non-invasive diagnostic technology. Our mission is to partner with clinicians and empower women through early, accurate breast cancer diagnostics—improving outcomes and confidence in care.
What we do
BCAL Diagnostics Limited is advancing non-invasive breast cancer screening with a simple blood test designed to complement existing imaging technologies.
Initially developed to support mammograms, our solutions aim to evolve into a comprehensive screening and monitoring approach for women. Through close partnership with clinicians, we empower women with earlier, more accurate breast cancer diagnostics—delivering greater choice and confidence in their breast health journey.
Making an Impact
For over a decade, BCAL Diagnostics has been developing a non-invasive diagnostic tool designed to enhance breast cancer screening – resulting in a simple blood test that complements mammography to rule out breast cancer in women over 30 with high breast density.
Source: * Breast Cancer Statistics, Breast Cancer Trials est. 2024 figures https://www.breastcancertrials.org.au/breast-cancer-resources/breast-cancer-statistics
